- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03982836
Impact of Different Dietary Fibers in Gastric Emptying Time and Intestinal Transit of Healthy Volunteers
June 10, 2019 updated by: Maria Isabel Toulson Davisson Correia, Federal University of Minas Gerais
The digestive process begins in the mouth and follows in the stomach and intestine.
In the stomach the food is mixed with the gastric juices forming the chyme.
To mix the food with the gastric juice as well as to provide gastric emptying (GE), the movements of the stomach are of great importance.
Intestinal transit time is understood of the combination of GE, small intestine transit and colon transit time.
The composition of the diet (lipid and protein content) exerts a direct influence on intestinal transit time due to the stimulation of hormone secretion, cholecystokinin and gastrin, respectively, which act to decrease GE velocity.
In this context, it is also observed an important influence of dietary fibers on the speed of GE.
Despite all knowledge about dietary fibers, information on such compounds still has many controversies.
Due to the difficulty of finding compounds that fit into only one specific category (viscous, fermentable or prebiotic) there is difficulty in establishing a concept that best defines what are dietary fibers.
The CODEX Alimentarius Commission in 2009 defined dietary fibers as carbohydrate polymers composed of ten or more monomer units of this macronutrient, which are not hydrolyzed by enzymes in the human intestine.
Dietary fibers can be classified into insoluble and soluble according to the ability to bind to water molecules and form gels. Soluble fibers, especially those classified as prebiotic, in the intestine are fermented by bacteria giving rise to short chain fatty acids (SCFA).
The SCFA stimulates the production and secretion of PYY and GLP-1 are associated with inhibition of gastric motility.
Due to the importance of knowing the intestinal transit time, several methods have been developed, but scintigraphy is the gold standard technique for this analysis.
Given the above and controversies present in the literature on the dietary fibers, there was a shortage of studies with the objective of evaluating the impact of different dietary fibers in intestinal transit time.
This study shows relevant to help elucidate the behavior of different dietary fibers in intestinal transit time, offering data for correct and safe use of dietary fibers in various clinical situations.
The hypothesis of this study is that the partially hydrolyzed guar gum delays the time of gastric emptying and intestinal transit, being this effect not observed for fructooligosaccharide
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
MG
-
Belo Horizonte, MG, Brazil, 30130-100
- Escola de Enfermagem - UFMG
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy volunteers;
- Both sexes;
- Age Range:From 18 to 40 years old
- Volunteers who do not have gluten or egg restriction
- No history or diagnosis of gastrointestinal diseases;
- Had not undergone recent operations that compromised intestinal transit time and / or gastric emptying.
Exclusion Criteria:
- Volunteers who used prebiotic, probiotic and / or symbiotic volunteers at least 10 days prior to study day;
- Volunteers diagnosed with hypothyroidism and / or diabetes or who reported hypoglycemia and not tolerance to fasting;
- Women were asked about pregnancy, suspected pregnancy, use of contraceptive methods and menstrual cycle. If there was any possibility of pregnancy, based on these questions, the volunteer was excluded from the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Fructooligosaccharide
All the 25 volunteers received the sandwich containing 20 grams of fructooligosaccharide
|
All 25 volunteers received, were separated for 7 days of washout, one containing maltodextrin (control), Frutooligossacharide or guar gum partially hydrolyzed in a randomized manner.
As the partially hydrolyzed guar gum and fructooligosaccharide, soluble dietary fibers that present different behaviors in the body.
Other Names:
|
EXPERIMENTAL: Partially hydrolyzed guar gum
All the 25 volunteers received the sandwich containing 20 grams of partially hydrolyzed guar gum
|
All 25 volunteers received, were separated for 7 days of washout, one containing maltodextrin (control), Frutooligossacharide or guar gum partially hydrolyzed in a randomized manner.
As the partially hydrolyzed guar gum and fructooligosaccharide, soluble dietary fibers that present different behaviors in the body.
Other Names:
|
PLACEBO_COMPARATOR: Maltodextrin
All the 25 volunteers received the sandwich containing 20 grams of Maltodextrin
|
All 25 volunteers received, were separated for 7 days of washout, one containing maltodextrin (control), Frutooligossacharide or guar gum partially hydrolyzed in a randomized manner.
As the partially hydrolyzed guar gum and fructooligosaccharide, soluble dietary fibers that present different behaviors in the body.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gastric Emptying Time and intestinal transit time
Time Frame: After the 3rd day of the protocol
|
The impact of the fibers under the gastric emptying and intestinal transit time is evaluated after the volunteer performs the ingestion of the 3 modules on different days.
|
After the 3rd day of the protocol
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intestinal Hormones Concentrations
Time Frame: Up to 3 weeks after protocol termination
|
Dosage of serum concentrations
|
Up to 3 weeks after protocol termination
|
Compare gastric emptying and intestinal transit times between dietary fiber types
Time Frame: Up to 3 weeks after protocol termination
|
To compare how the fibers influenced the time of gastric emptying and intestinal transit
|
Up to 3 weeks after protocol termination
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Simone V Generoso, Federal University of Minas Gerais
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 21, 2018
Primary Completion (ACTUAL)
April 13, 2019
Study Completion (ANTICIPATED)
July 27, 2019
Study Registration Dates
First Submitted
May 21, 2019
First Submitted That Met QC Criteria
June 10, 2019
First Posted (ACTUAL)
June 12, 2019
Study Record Updates
Last Update Posted (ACTUAL)
June 12, 2019
Last Update Submitted That Met QC Criteria
June 10, 2019
Last Verified
June 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CAAE: 85797918.1.0000.5149
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastric Emptying
-
Columbia UniversityRecruiting
-
Medical University of ViennaCompleted
-
University of BergenThe Research Council of NorwayCompleted
-
Mayo ClinicCompletedGastric EmptyingUnited States
-
Air Force Military Medical University, ChinaCompleted
-
Coombe Women and Infants University HospitalCompleted
-
Kangbuk Samsung HospitalUnknown
-
Maastricht University Medical CenterUnilever R&DCompleted
-
Guy's and St Thomas' NHS Foundation TrustCompleted
-
University Children's Hospital, ZurichCompleted
Clinical Trials on Soluble Dietary Fibers
-
University of MinnesotaNestléCompleted
-
Jinling Hospital, ChinaTerminated
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Oslo University HospitalNorwegian Extra Foundation for Health and Rehabilitation; Norwegian Diabetes...Completed
-
Tel-Aviv Sourasky Medical CenterUnknown
-
Weizmann Institute of ScienceHadassah Medical OrganizationRecruitingDietary Fibers | Intermediate FastingIsrael
-
Laboratorios OrdesaUnknown
-
NestléCompletedMicrobiota Perturbation by an Environmental ChallengeSwitzerland
-
University of ZagrebCroatian Science FoundationCompletedMicrobiota | Sports | Dietary Fiber | Nutrition Surveys | Sports NutritionCroatia
-
University of GlasgowMondelēz International, Inc.RecruitingGastrointestinal DiscomfortUnited Kingdom